| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6143740 |
Heregulin antagonists and methods for their use |
Nov. 7, 2000 |
| 6140317 |
Pyrrolopyrimidines and processes for their preparation |
Oct. 31, 2000 |
| 6133280 |
Androgen synthesis inhibitors |
Oct. 17, 2000 |
| 6133282 |
Certain pyrrolopyridine derivatives; novel CRF1 specific ligands |
Oct. 17, 2000 |
| 6130212 |
Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof |
Oct. 10, 2000 |
| 6130231 |
Integrin receptor antagonists |
Oct. 10, 2000 |
| 6127354 |
Compounds with growth hormone releasing properties |
Oct. 3, 2000 |
| 6127355 |
High molecular weight polymer-based prodrugs |
Oct. 3, 2000 |
| 6127377 |
Vinca alkaloid antimitotic halogenated derivatives |
Oct. 3, 2000 |
| 6127391 |
Compounds with growth hormone releasing properties |
Oct. 3, 2000 |
| 6124277 |
Antithrombotic agents |
Sep. 26, 2000 |
| 6124298 |
Pyrazinedicarboxylic-acid derivatives as cell proliferation regulators |
Sep. 26, 2000 |
| 6121257 |
Sulfamate containing macrocyclic immunomodulators |
Sep. 19, 2000 |
| 6121272 |
Bidentate metalloprotease inhibitors |
Sep. 19, 2000 |
| 6117861 |
Protein kinase C inhibitor |
Sep. 12, 2000 |
| 6114320 |
Therapeutic treatment for VEGF related ocular diseases |
Sep. 5, 2000 |
| 6114321 |
Porphyrin derivatives, pharmaceutical agents that contain the latter, and their use in photodynamic therapy and MRI diagnosis |
Sep. 5, 2000 |
| 6103706 |
Methods for treating viral infections |
Aug. 15, 2000 |
| 6103711 |
Inhibitors of interleukin-1.beta. converting enzyme |
Aug. 15, 2000 |
| 6103712 |
Therapeutic treatment for asthma |
Aug. 15, 2000 |
| 6103713 |
Therapeutic treatment for autoimmune diseases |
Aug. 15, 2000 |
| 6103751 |
Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents |
Aug. 15, 2000 |
| 6093709 |
Therapeutic treatment for sexual dysfunctions |
Jul. 25, 2000 |
| 6093710 |
Benzothiophene derivatives, their preparation and use as urokinase inhibitors |
Jul. 25, 2000 |
| 6093733 |
Muscarinic receptor agonists |
Jul. 25, 2000 |
| 6093748 |
Inhibition of hair growth |
Jul. 25, 2000 |
| 6090804 |
Thiophene derivative and pharmaceutical composition thereof |
Jul. 18, 2000 |
| 6083917 |
Methods and compositions for the identification, characterization and inhibition of farnesyltransferase |
Jul. 4, 2000 |
| 6075016 |
6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
Jun. 13, 2000 |
| 6071913 |
Angiotensin II receptor antagonistic 1,2,4-triazin-5-one derivatives |
Jun. 6, 2000 |
| 6071970 |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Jun. 6, 2000 |
| 6066628 |
Non-iron metalloporphyrins and methods of use |
May. 23, 2000 |
| 6063777 |
Iminochlorinaspartic acid derivatives |
May. 16, 2000 |
| 6060466 |
Potentiation of the microbicide 2-(Thiocyanomethylthio)benzothiazole using an N-alkyl heterocyclic compound |
May. 9, 2000 |
| 6057310 |
Organoselenium compounds with pro-oxidant activity and pharmaceutical use thereof |
May. 2, 2000 |
| 6057311 |
Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors |
May. 2, 2000 |
| 6057322 |
Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them |
May. 2, 2000 |
| 6057323 |
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
May. 2, 2000 |
| 6054448 |
2-amino-2-(3-substituted cyclobutyl) acetic acid derivatives |
Apr. 25, 2000 |
| 6051592 |
Acyl-mercapto-triazolyl derivatives and the use thereof as microbicides |
Apr. 18, 2000 |
| 6048850 |
Method of inhibiting prostaglandin synthesis in a human host |
Apr. 11, 2000 |
| 6046163 |
Cyclosporin formulation |
Apr. 4, 2000 |
| 6043261 |
Pyrrolodino imidines useful as nitric oxide synthase inhibitors |
Mar. 28, 2000 |
| 6040317 |
Sulfonamide fibrinogen receptor antagonists |
Mar. 21, 2000 |
| 6037326 |
Reduction of hair growth |
Mar. 14, 2000 |
| 6037340 |
Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds |
Mar. 14, 2000 |
| 6030964 |
Mono- or polyenic carboxylic acid derivatives |
Feb. 29, 2000 |
| 6030971 |
Methods and compositions for controlling biofouling using amides |
Feb. 29, 2000 |
| 6028097 |
Method of immunosuppression |
Feb. 22, 2000 |
| 6028103 |
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation |
Feb. 22, 2000 |
|
|
|
